Enteroviruses as causative agents in type 1 diabetes: Loose ends or lost cause?

Trends in Endocrinology and Metabolism

Volumn 25, Issue 12, 2014, Pages 611-619

  Morgan, Noel G ^a   Richardson, Sarah J ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

Coxsackievirus; Islets of langerhans; Pathogen recognition receptors; Persistent infection; Type 1 diabetes

Indexed keywords

INTERFERON; PROTEIN KINASE R;

AUTOIMMUNITY; CELL DIFFERENTIATION; ENTEROVIRUS; ENTEROVIRUS INFECTION; HUMAN; INFECTION SENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

EID: 85027942576     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.08.002     Document Type: Review

References (84)

1. Tracy S., et al. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev. Med. Virol. 2010, 20:106-116.
2. Craig M.E., et al. Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J. Infect. Dis. 2003, 187:1562-1570.
3. Laitinen O.H., et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 2014, 63:446-455.
4. Moya-Suri V., et al. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies. J. Med. Microbiol. 2005, 54:879-883.
5. Nairn C., et al. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus. Diabet. Med. 1999, 16:509-513.
6. Oikarinen S., et al. Virus antibody survey in different European populations indicates risk association between Coxsackievirus B1 and type 1 diabetes. Diabetes 2014, 63:655-662.
7. Salminen K., et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J. Med. Virol. 2003, 69:91-98.
8. Salvatoni A., et al. Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes. Pediatr. Diabetes 2013, 14:407-416.
9. Sarmiento L., et al. Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes. Autoimmunity 2007, 40:540-545.
10. Schulte B.M., et al. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol. 2010, 23:99-104.
11. Yeung W.C., et al. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ Clin. Res. 2011, 342:d35.
12. Sarmiento L., et al. Evidence of association between type 1 diabetes and exposure to enterovirus in Cuban children and adolescents. MEDICC Rev. 2013, 15:29-32.
13. Whitehead J.E. Viral epidemiology: the hidden universality of infection. Br. Med. J. 1972, 2:451-456.
14. Roep B.O., Tree T.I. Immune modulation in humans: implications for type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2014, 10:229-242.
15. Kaufman D.L., et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 1992, 89:283-292.
16. Hou J., et al. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from Coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994, 43:1260-1266.
17. Lonnrot M., et al. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of Coxsackievirus B4. Childhood Diabetes in Finland Study Group. Clin. Exp. Immunol. 1996, 104:398-405.
18. Marttila J., et al. Responses of Coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology 2001, 284:131-141.
19. Roep B.O., et al. Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann. N. Y. Acad. Sci. 2002, 958:163-165.
20. Schloot N.C., et al. T-cell reactivity to GAD65 peptide sequences shared with Coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia 1997, 40:332-338.
21. Afonso G., Mallone R. Infectious triggers in type 1 diabetes: is there a case for epitope mimicry?. Diabetes Obes. Metab. 2013, 15(Suppl. 3):82-88.
22. Oikarinen M., et al. Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin. Exp. Immunol. 2008, 151:71-75.
23. Yoon J.W., et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 1979, 300:1173-1179.
24. Dotta F., et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5115-5120.
25. Foulis A.K., et al. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of Coxsackieviral myocarditis. Diabetologia 1990, 33:290-298.
26. Andreoletti L., et al. Viral causes of human myocarditis. Arch. Cardiovasc. Dis. 2009, 102:559-568.
27. Harris K.G., Coyne C.B. Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling. Cytokine 2013, 63:230-236.
28. Welch J., et al. Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors. Transfusion 2003, 43:1060-1066.
29. Richardson S.J., et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009, 52:1143-1151.
30. Ylipaasto P., et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004, 47:225-239.
31. Hilton D.A., et al. Demonstration of Coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction. J. Pathol. 1993, 170:45-51.
32. Richardson S.J., et al. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 2013, 56:185-193.
33. Willcox A., et al. Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 2011, 54:2417-2420.
34. Stechova K., et al. Case report: type 1 diabetes in monozygotic quadruplets. Eur. J. Hum. Genet. 2012, 20:457-462.
35. Hilton D.A., et al. Demonstration of the distribution of Coxsackie virus RNA in neonatal mice by non-isotopic in situ hybridization. J. Virol. methods 1992, 40:155-162.
36. Alirezaei M., et al. Pancreatic acinar cell-specific autophagy disruption reduces Coxsackievirus replication and pathogenesis in vivo. Cell Host Microbe 2012, 11:298-305.
37. Moon M.S., et al. Distribution of viral RNA in mouse tissues during acute phase of Coxsackievirus B5 infection. Intervirology 2005, 48:153-160.
38. Spagnuolo I., et al. Pancreatic islet expression of enteroviral receptors and dsRNA sensors in human type 1 diabetes. Diabetologia 2013, 56:S139-S140.
39. Oikarinen M., et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008, 51:1796-1802.
40. Dorner A., et al. Alternatively spliced soluble Coxsackie-adenovirus receptors inhibit Coxsackievirus infection. J. Biol. Chem. 2004, 279:18497-18503.
41. Drescher K.M., et al. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004, 329:381-394.
42. Inal J.M., Jorfi S. Coxsackievirus B transmission and possible new roles for extracellular vesicles. Biochem. Soc. Trans. 2013, 41:299-302.
43. Kim K.S., et al. 5'-Terminal deletions occur in Coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J. Virol. 2005, 79:7024-7041.
44. Elshebani A., et al. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res. 2007, 124:193-203.
45. Hodik M., et al. Tropism analysis of two Coxsackie B5 strains reveals virus growth in human primary pancreatic islets but not in exocrine cell clusters in vitro. Open Virol. J. 2013, 7:49-56.
46. Anagandula M., et al. Infection of human islets of langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J. Med. Virol. 2014, 86:1402-1411.
47. Tanaka S., et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes 2009, 58:2285-2291.
48. Kobayashi T., et al. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes Metab. Res. Rev. 2011, 27:965-970.
49. Tanaka S., et al. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes. Endocr. J. 2013, 60:837-845.
50. Sayama K., et al. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment. Diabetologia 2005, 48:1560-1564.
51. Foulis A.K., et al. Massive synchronous B-cell necrosis causing type 1 (insulin-dependent) diabetes - a unique histopathological case report. Diabetologia 1988, 31:46-50.
52. Chapman N.M., et al. 5' terminal deletions in the genome of a Coxsackievirus B2 strain occurred naturally in human heart. Virology 2008, 375:480-491.
53. Kim K.S., et al. Replication of Coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J. Virol. 2008, 82:2033-2037.
54. Skog O., et al. Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and isolated islets of Langerhans. J. Clin. Virol. 2014, 10.1016/j.jcv.2014.07.014.
55. Sane F., et al. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell. Mol. Life Sci. 2013, 70:4169-4180.
56. Lysy P.A., et al. Making beta cells from adult cells within the pancreas. Curr. Diab. Rep. 2013, 13:695-703.
57. Cunningham L., et al. Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J. Gen. Virol. 1990, 71:1399-1402.
58. Klingel K., et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:314-318.
59. Tam P.E., Messner R.P. Molecular mechanisms of Coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J. Virol. 1999, 73:10113-10121.
60. Hultcrantz M., et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology 2007, 367:92-101.
61. Shibasaki S., et al. Expression of Toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr. J. 2010, 57:211-219.
62. Aida K., et al. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes. Diabetes 2011, 60:884-889.
63. Lind K., et al. Induction of an antiviral state and attenuated Coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J. Virol. 2013, 87:7646-7654.
64. Pichlmair A., et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 2009, 83:10761-10769.
65. Richardson S.J., et al. Enteroviral capsid protein, VP1, co-localises with protein kinase R in the islets of patients with recent-onset type 1 diabetes. Diabet. Med. 2011, 28:13.
66. Downes K., et al. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS ONE 2010, 5:e12646.
67. Winkler C., et al. An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes 2011, 60:685-690.
68. Nejentsev S., et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
69. Liu S., et al. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum. Mol. Genet. 2009, 18:358-365.
70. Foulis A.K., et al. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987, 30:333-343.
71. Bottazzo G.F., et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 1985, 313:353-360.
72. Richardson S.J., et al. Pancreatic pathology in type 1 diabetes mellitus. Endocr. Pathol. 2014, 25:80-92.
73. Foulis A.K., et al. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987, 2:1423-1427.
74. Huang X., et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995, 44:658-664.
75. Coppieters K.T., et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 2012, 209:51-60.
76. Quah H.S., et al. Deficiency in type I interferon signaling prevents the early interferon-induced gene signature in pancreatic islets but not type 1 diabetes in NOD mice. Diabetes 2014, 63:1032-1040.
77. Ferreira R.C., et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 2014, 63:2538-2550.
78. Kallionpaa H., et al. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes 2014, 63:2402-2414.
79. Skog O., et al. Modulation of innate immunity in human pancreatic islets infected with enterovirus in vitro. J. Med. Virol. 2011, 83:658-664.
80. Ylipaasto P., et al. Global profiling of Coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005, 48:1510-1522.
81. Skaug B., Chen Z.J. Emerging role of ISG15 in antiviral immunity. Cell 2010, 143:187-190.
82. Levin D., et al. Multifaceted activities of type I interferon are revealed by a receptor antagonist. Sci. Signal. 2014, 7:ra50.
83. Flodstrom-Tullberg M., et al. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during Coxsackievirus infection. J. Immunol. 2005, 174:1171-1177.
84. Garcia M.A., et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 2006, 70:1032-1060.